Corey Scott, PhD, is a Principal Nutrition Scientist with Cargill in Minneapolis, Minnesota, where he leads global nutritional research on sweeteners and carbohydrates. He currently serves as a steering team member and work package leader for Project SWEET (a five-year EU Consortium project evaluating sweeteners). He is the Chair of the Institute for the Advancement of Food and Nutrition Sciences Low- and Non-caloric Sweetener Committee, Chair of the North Carolina Agricultural and Life Sciences at North Carolina State University Technical Advisory and Finance Committee, and an industry advisor for the University and Industry Consortium/Foundation for Food and Agriculture Research Sally Rockey Fellowship. Dr. Scott holds a doctorate degree in food science and nutrition from Ohio State University, a master’s degree in chemistry from North Carolina A&T State University, and a bachelor’s degree in chemistry from the University of North Carolina at Chapel Hill. 

Julie Miller, PhD, Public Health Toxicologist, Pennsylvania Department of Public Health, is a board-certified toxicologist with primary training and expertise in analytical chemistry, in vitro and alternative methods, toxicology study design, data analysis and interpretation, and mixtures toxicology.

Dr. Miller received her PhD from the Department of Chemistry at West Virginia University, where her dissertation utilized early cellular changes to explore biological responses to individual chemical and mixture exposures. Dr. Miller received postdoctoral training at the US Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (CDC/NIOSH), where she evaluated neurobiochemical alterations in vivo after exposure to a mixture of stress and occupational and/or environmental chemical insult to further elucidate the role stress plays in physiological response to external stimuli.

The overall goal of Lisa Truong's research program is to utilize the zebrafish model to help build computational predictive toxicity models. Secondarily, she aims to move the field to be less reliant on animal testing and to conduct toxicity-testing based on toxicity pathways. Dr. Truong has a Bachelor’s degree in pre-pharmacy with a minor in chemistry, which provided the foundation to evaluate a structurally diverse class of fluorinated compounds during her Master's studies. Her PhD thesis was focused on developing rapid in vivo assays to investigate structure response relationships using larval and adult zebrafish. Using the methods that Dr. Truong developed, the zebrafish developmental toxicity screen is now fully automated at the Sinnhuber Aquatic Research Laboratory (SARL). 

Nivetha Kamalavannan Subramaniam is a PhD student at McGill University in Canada. She is the recipient of the McGill Dr. Morris Karmazyn and Dr. Margaret P. Moffat Fellowship in Cardiovascular Research. The title of her PhD thesis project is "The Pro-atherogenic Effects of Arsenic and Cadmium Mixtures."

Ms. Subramaniam serves as the Graduate Student Representative for the SOT Metals Specialty Section, and in 2023, she received the second place prize from the SOT Metals Specialty Section Student Research Award Fund.

Noah Whiteman, PhD, is Professor of Genetics, Genomics, Evolution, and Development in the Department of Molecular & Cell Biology and the Department of Integrative Biology at University of California (UC) Berkeley. His laboratory focuses on understanding why and how organisms deploy toxins as weapons that they use in offense and defense. Dr. Whiteman is Co-director of the NIH T32 Genetic Dissection of Cells and Organisms Training Program that provides training to 16 PhD students in genetics.

Dr. Whiteman conducted his dissertation research in the Galapagos Islands on co-evolution between birds and their parasites. He then completed an NIH postdoctoral fellowship at Harvard where he began to use plants as model hosts that were attacked by diverse parasites. At UC Berkeley, his laboratory focuses on how plants have evolved to produce diverse toxins as defensive shields and how insects have evolved in response to resist and even sequester them.

Samantha Snow, PhD, DABT, is a Director of Toxicology at ICF specializing in risk assessment projects, toxicological and epidemiological study summaries and reviews, literature reviews, technical writing, hazard assessments, and health and risk communication. She completed a postdoctoral fellowship at the US EPA Cardiopulmonary Immunology Branch, where her research interests were wide and included examining neuroendocrine regulation of ozone-induced cardiopulmonary, systemic, and metabolic responses. Dr. Snow has a PhD in toxicology from the University of North Carolina at Chapel Hill and is certified as a Diplomate of the American Board of Toxicology. She has been an active member of SOT since 2010, serving in the following capacities: Out Toxicologists and Allies Founding Member (2019) and President (2022–2023); Postdoctoral Assembly Chair (2017–2018); North Carolina Regional Chapter Councilor (2016–2018) and Postdoctoral Representative (2013–2015); and more.

Stephen M. Fiore, PhD, is Director, Cognitive Sciences Laboratory, and Professor with the University of Central Florida's Cognitive Sciences Program in the Department of Philosophy and School of Modeling, Simulation, and Training. He maintains a multidisciplinary research interest that incorporates aspects of the cognitive, social, organizational, and computational sciences in the investigation of learning and performance in individuals and teams. His primary area of research is the interdisciplinary study of complex collaborative cognition and the understanding of how humans interact socially and with technology.

William “Bill” J. Sullivan, PhD, has been studying the intracellular parasite Toxoplasma gondii since he was a graduate student in the lab of Dr. David Roos at the University of Pennsylvania in 1994. He completed postdoctoral fellowships with Dr. Chuck Smith at ELANCO (a division of Eli Lilly, Co.) and Dr. Sherry Queener at the Indiana University School of Medicine. He became an Assistant Professor at the Indiana University School of Medicine in 2003. Dr. Sullivan is now the Showalter Professor of Pharmacology & Toxicology and Microbiology & Immunology at the Indiana University School of Medicine.

Dr. Sullivan’s lab studies cellular signaling and the regulation of gene expression in Toxoplasma gondii. Toxoplasma causes congenital birth defects and opportunistic infection in HIV/AIDS, cancer chemotherapy, and heart transplant patients. There is also emerging evidence that this parasitic infection may be linked to neurological disorders.